Hyalex Orthopaedics is an award-winning, medical device start-up developing transformational synthetic cartilage technology and implant systems for diseased and damaged joints. The company’s products, which are currently being advanced to the clinic, are based on its platform technology, HYALEX® Synthetic Cartilage – the first synthetic cartilage material engineered to mimic the properties of native hyaline cartilage. The company’s leadership team has over 150 years of combined experience in cartilage and orthopaedics and has raised more than $33MM in Series A funding from venture investors including Canaan Partners, Osage University Partners, Johnson & Johnson Innovation, and Strategic Healthcare Investment Partners. Hyalex is headquartered in Lexington, MA.